Microglia-Derived Interleukin-6 Triggers Astrocyte Apoptosis in the Hippocampus and Mediates Depression-Like Behavior.

A New Clue About Depression: How Brain Cells Turn Against Each Other

Researchers have uncovered an important piece of the depression puzzle — and it involves two types of brain cells that are supposed to work together but can end up causing harm to one another.

In people with major depressive disorder (MDD), studies have long noted that certain brain cells called astrocytes shrink and die, particularly in the hippocampus, the brain region involved in mood and memory. But scientists weren't entirely sure why this happened. This new study points to another type of brain cell — microglia — as a key culprit.

Microglia are the brain's immune cells. When you're under stress, they activate and release inflammatory chemicals. This study found that one of those chemicals, a protein called interleukin-6 (IL-6), directly triggers astrocyte death. The more stress the brain experiences, the more IL-6 is released, and the more astrocytes are lost — contributing to depression-like symptoms.

The researchers used a chronic social stress model in animals and were able to reduce depression-like behaviors by blocking either the IL-6 signal in microglia or the IL-6 receptor on astrocytes. They also found that a receptor called P2X7, which responds to stress signals, plays a key role in switching microglia into their harmful, activated state.

What does this mean for people dealing with depression? It reinforces the idea that inflammation in the brain is a real, measurable driver of depressive symptoms — not just a side effect. It also highlights why approaches that calm neuroinflammation, such as acupuncture, are of growing interest to researchers and clinicians. Acupuncture has been studied for its ability to modulate inflammatory pathways and support nervous system balance.

If you are living with depression and curious about acupuncture as part of your care plan, speak with a licensed acupuncturist who has experience supporting mental health conditions.

This study, published in Advanced Science, utilized a chronic social defeat stress (CSDS) mouse model to investigate the mechanistic link between microglial activation and astrocyte loss in the hippocampus — two established pathological features of major depressive disorder (MDD).

Key findings demonstrate that CSDS induces significant anxiety- and depression-like behavior concurrent with astrocyte atrophy and apoptosis, microglial activation, and elevated microglial interleukin-6 (IL-6). Mechanistically, IL-6 secreted by activated microglia was shown to directly promote astrocyte apoptosis. Upstream, P2X7 receptor (P2X7R) activation on microglia was identified as a critical mediator of stress-induced microglial activation and IL-6 release. Selective knockdown of microglial IL-6 and astrocytic IL-6 receptors each independently attenuated depression-like behaviors and reduced astrocyte atrophy. Minocycline-mediated microglial inhibition corroborated these results.

Clinical takeaway: The IL-6/IL-6R signaling axis represents a tractable neuroinflammatory target in depression. For acupuncture practitioners, this supports the clinical rationale for anti-inflammatory treatment strategies, as acupuncture has demonstrated modulatory effects on IL-6 and microglial activity in preclinical literature.